Human Papillomavirus Vaccination: Past, Present and Future

doi:10.3390/vaccines10091398

Editorial

. 2022 Aug 26;10(9):1398.

doi: 10.3390/vaccines10091398.

Human Papillomavirus Vaccination: Past, Present and Future

Gulzhanat Aimagambetova¹, Azliyati Azizan²

Affiliations

¹ Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
² Basic Sciences Department, College of Osteopathic Medicine, Touro University Nevada, Henderson, NV 89014, USA.

PMID: 36146476
PMCID: PMC9506101
DOI: 10.3390/vaccines10091398

Editorial

Human Papillomavirus Vaccination: Past, Present and Future

Gulzhanat Aimagambetova et al. Vaccines (Basel). 2022.

. 2022 Aug 26;10(9):1398.

doi: 10.3390/vaccines10091398.

Authors

Gulzhanat Aimagambetova¹, Azliyati Azizan²

Affiliations

¹ Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Nur-Sultan 010000, Kazakhstan.
² Basic Sciences Department, College of Osteopathic Medicine, Touro University Nevada, Henderson, NV 89014, USA.

PMID: 36146476
PMCID: PMC9506101
DOI: 10.3390/vaccines10091398

Abstract

The link between human papillomavirus (HPV) infection and different diseases has been well-established since more than four decades ago [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Cited by

Cervicovaginal Microbiome: Physiology, Age-Related Changes, and Protective Role Against Human Papillomavirus Infection.
Alizhan D, Ukybassova T, Bapayeva G, Aimagambetova G, Kongrtay K, Kamzayeva N, Terzic M. Alizhan D, et al. J Clin Med. 2025 Feb 24;14(5):1521. doi: 10.3390/jcm14051521. J Clin Med. 2025. PMID: 40094958 Free PMC article. Review.
Prevalence of high-risk human papillomavirus infection and genotype distribution among Kazakhstani women with abnormal cervical cytology.
Babi A, Issa T, Gusmanov A, Akilzhanova A, Issanov A, Makhmetova N, Marat A, Iztleuov Y, Aimagambetova G. Babi A, et al. Ann Med. 2024 Dec;56(1):2304649. doi: 10.1080/07853890.2024.2304649. Epub 2024 Jan 18. Ann Med. 2024. PMID: 38237138 Free PMC article.
Reproductive and Obstetric Outcomes after Fertility-Sparing Treatments for Cervical Cancer: Current Approach and Future Directions.
Terzic M, Makhadiyeva D, Bila J, Andjic M, Dotlic J, Aimagambetova G, Sarria-Santamera A, Laganà AS, Chiantera V, Vukovic I, Kocijancic Belovic D, Aksam S, Bapayeva G, Terzic S. Terzic M, et al. J Clin Med. 2023 Mar 30;12(7):2614. doi: 10.3390/jcm12072614. J Clin Med. 2023. PMID: 37048696 Free PMC article. Review.
Prevalence of Precancerous Cervical Lesions among Nonvaccinated Kazakhstani Women: The National Tertiary Care Hospital Screening Data (2018).
Imankulova B, Babi A, Issa T, Zhumakanova Z, Knaub L, Yerzhankyzy A, Aimagambetova G. Imankulova B, et al. Healthcare (Basel). 2023 Jan 12;11(2):235. doi: 10.3390/healthcare11020235. Healthcare (Basel). 2023. PMID: 36673606 Free PMC article.
Primary prevention of HPV-related diseases from the patients' perspective in Poland.
Trojnarska D, Jach R. Trojnarska D, et al. Eur J Cancer Prev. 2024 Jul 1;33(4):299-308. doi: 10.1097/CEJ.0000000000000866. Epub 2023 Nov 30. Eur J Cancer Prev. 2024. PMID: 38113130 Free PMC article.

References

1. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer. 2002;2:342–350. doi: 10.1038/nrc798. - DOI - PubMed
1. zur Hausen H. Papillomaviruses in the causation of human cancers—A brief historical account. Virology. 2009;384:260–265. doi: 10.1016/j.virol.2008.11.046. - DOI - PubMed
1. Garland S.M., Kjaer S.K., Muñoz N., Block S.L., Brown D.R., DiNubile M.J., Lindsay B.R., Kuter B.J., Perez G., Dominiak-Felden G., et al. Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience. Clin. Infect. Dis. 2016;63:519–527. doi: 10.1093/cid/ciw354. - DOI - PMC - PubMed
1. Patel C., Brotherton J.M., Pillsbury A., Jayasinghe S., Donovan B., Macartney K., Marshall H. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: What additional disease burden will a nonavalent vaccine prevent? Euro Surveill. 2018;23:1700737. doi: 10.2807/1560-7917.ES.2018.23.41.1700737. - DOI - PMC - PubMed
1. Dilley S., Miller K.M., Huh W.K. Human papillomavirus vaccination: Ongoing challenges and future directions. Gynecol. Oncol. 2020;156:498–502. doi: 10.1016/j.ygyno.2019.10.018. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

[1] zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer. 2002;2:342–350. doi: 10.1038/nrc798. - DOI - PubMed

[2] zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer. 2002;2:342–350. doi: 10.1038/nrc798. - DOI - PubMed

[3] zur Hausen H. Papillomaviruses in the causation of human cancers—A brief historical account. Virology. 2009;384:260–265. doi: 10.1016/j.virol.2008.11.046. - DOI - PubMed

[4] zur Hausen H. Papillomaviruses in the causation of human cancers—A brief historical account. Virology. 2009;384:260–265. doi: 10.1016/j.virol.2008.11.046. - DOI - PubMed

[5] Garland S.M., Kjaer S.K., Muñoz N., Block S.L., Brown D.R., DiNubile M.J., Lindsay B.R., Kuter B.J., Perez G., Dominiak-Felden G., et al. Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience. Clin. Infect. Dis. 2016;63:519–527. doi: 10.1093/cid/ciw354. - DOI - PMC - PubMed

[6] Garland S.M., Kjaer S.K., Muñoz N., Block S.L., Brown D.R., DiNubile M.J., Lindsay B.R., Kuter B.J., Perez G., Dominiak-Felden G., et al. Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience. Clin. Infect. Dis. 2016;63:519–527. doi: 10.1093/cid/ciw354. - DOI - PMC - PubMed

[7] Patel C., Brotherton J.M., Pillsbury A., Jayasinghe S., Donovan B., Macartney K., Marshall H. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: What additional disease burden will a nonavalent vaccine prevent? Euro Surveill. 2018;23:1700737. doi: 10.2807/1560-7917.ES.2018.23.41.1700737. - DOI - PMC - PubMed

[8] Patel C., Brotherton J.M., Pillsbury A., Jayasinghe S., Donovan B., Macartney K., Marshall H. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: What additional disease burden will a nonavalent vaccine prevent? Euro Surveill. 2018;23:1700737. doi: 10.2807/1560-7917.ES.2018.23.41.1700737. - DOI - PMC - PubMed

[9] Dilley S., Miller K.M., Huh W.K. Human papillomavirus vaccination: Ongoing challenges and future directions. Gynecol. Oncol. 2020;156:498–502. doi: 10.1016/j.ygyno.2019.10.018. - DOI - PMC - PubMed

[10] Dilley S., Miller K.M., Huh W.K. Human papillomavirus vaccination: Ongoing challenges and future directions. Gynecol. Oncol. 2020;156:498–502. doi: 10.1016/j.ygyno.2019.10.018. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Human Papillomavirus Vaccination: Past, Present and Future

Affiliations

Human Papillomavirus Vaccination: Past, Present and Future

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

Related information

LinkOut - more resources

Full Text Sources

Miscellaneous